Global Bio-pharma Market Insights, Forecast to 2029

Global Bio-pharma Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Bio-pharma Product Introduction
1.2 Market by Type
1.2.1 Global Bio-pharma Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Recombinant Proteins
1.2.4 Granulocyte-Colony Stimulating Factor (G-CSF)
1.2.5 Interferons
1.2.6 Recombinant Human Insulin
1.2.7 Erythropoietin
1.2.8 Vaccines
1.2.9 Growth Hormones
1.2.10 Purified Proteins
1.2.11 Others
1.3 Market by Application
1.3.1 Global Bio-pharma Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Metabolic Disorders
1.3.3 Oncology
1.3.4 Neurological Disorders
1.3.5 Cardiovascular Diseases
1.3.6 Inflammatory and Infectious Diseases
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bio-pharma Sales Estimates and Forecasts 2018-2029
2.2 Global Bio-pharma Revenue by Region
2.2.1 Global Bio-pharma Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Bio-pharma Revenue by Region (2018-2023)
2.2.3 Global Bio-pharma Revenue by Region (2024-2029)
2.2.4 Global Bio-pharma Revenue Market Share by Region (2018-2029)
2.3 Global Bio-pharma Sales Estimates and Forecasts 2018-2029
2.4 Global Bio-pharma Sales by Region
2.4.1 Global Bio-pharma Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Bio-pharma Sales by Region (2018-2023)
2.4.3 Global Bio-pharma Sales by Region (2024-2029)
2.4.4 Global Bio-pharma Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Bio-pharma Sales by Manufacturers
3.1.1 Global Bio-pharma Sales by Manufacturers (2018-2023)
3.1.2 Global Bio-pharma Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bio-pharma in 2022
3.2 Global Bio-pharma Revenue by Manufacturers
3.2.1 Global Bio-pharma Revenue by Manufacturers (2018-2023)
3.2.2 Global Bio-pharma Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Bio-pharma Revenue in 2022
3.3 Global Key Players of Bio-pharma, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Bio-pharma Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Bio-pharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Bio-pharma, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Bio-pharma, Product Offered and Application
3.8 Global Key Manufacturers of Bio-pharma, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bio-pharma Sales by Type
4.1.1 Global Bio-pharma Historical Sales by Type (2018-2023)
4.1.2 Global Bio-pharma Forecasted Sales by Type (2024-2029)
4.1.3 Global Bio-pharma Sales Market Share by Type (2018-2029)
4.2 Global Bio-pharma Revenue by Type
4.2.1 Global Bio-pharma Historical Revenue by Type (2018-2023)
4.2.2 Global Bio-pharma Forecasted Revenue by Type (2024-2029)
4.2.3 Global Bio-pharma Revenue Market Share by Type (2018-2029)
4.3 Global Bio-pharma Price by Type
4.3.1 Global Bio-pharma Price by Type (2018-2023)
4.3.2 Global Bio-pharma Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Bio-pharma Sales by Application
5.1.1 Global Bio-pharma Historical Sales by Application (2018-2023)
5.1.2 Global Bio-pharma Forecasted Sales by Application (2024-2029)
5.1.3 Global Bio-pharma Sales Market Share by Application (2018-2029)
5.2 Global Bio-pharma Revenue by Application
5.2.1 Global Bio-pharma Historical Revenue by Application (2018-2023)
5.2.2 Global Bio-pharma Forecasted Revenue by Application (2024-2029)
5.2.3 Global Bio-pharma Revenue Market Share by Application (2018-2029)
5.3 Global Bio-pharma Price by Application
5.3.1 Global Bio-pharma Price by Application (2018-2023)
5.3.2 Global Bio-pharma Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Bio-pharma Market Size by Type
6.1.1 US & Canada Bio-pharma Sales by Type (2018-2029)
6.1.2 US & Canada Bio-pharma Revenue by Type (2018-2029)
6.2 US & Canada Bio-pharma Market Size by Application
6.2.1 US & Canada Bio-pharma Sales by Application (2018-2029)
6.2.2 US & Canada Bio-pharma Revenue by Application (2018-2029)
6.3 US & Canada Bio-pharma Market Size by Country
6.3.1 US & Canada Bio-pharma Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Bio-pharma Sales by Country (2018-2029)
6.3.3 US & Canada Bio-pharma Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Bio-pharma Market Size by Type
7.1.1 Europe Bio-pharma Sales by Type (2018-2029)
7.1.2 Europe Bio-pharma Revenue by Type (2018-2029)
7.2 Europe Bio-pharma Market Size by Application
7.2.1 Europe Bio-pharma Sales by Application (2018-2029)
7.2.2 Europe Bio-pharma Revenue by Application (2018-2029)
7.3 Europe Bio-pharma Market Size by Country
7.3.1 Europe Bio-pharma Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Bio-pharma Sales by Country (2018-2029)
7.3.3 Europe Bio-pharma Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Bio-pharma Market Size
8.1.1 China Bio-pharma Sales (2018-2029)
8.1.2 China Bio-pharma Revenue (2018-2029)
8.2 China Bio-pharma Market Size by Application
8.2.1 China Bio-pharma Sales by Application (2018-2029)
8.2.2 China Bio-pharma Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Bio-pharma Market Size by Type
9.1.1 Asia Bio-pharma Sales by Type (2018-2029)
9.1.2 Asia Bio-pharma Revenue by Type (2018-2029)
9.2 Asia Bio-pharma Market Size by Application
9.2.1 Asia Bio-pharma Sales by Application (2018-2029)
9.2.2 Asia Bio-pharma Revenue by Application (2018-2029)
9.3 Asia Bio-pharma Sales by Region
9.3.1 Asia Bio-pharma Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Bio-pharma Revenue by Region (2018-2029)
9.3.3 Asia Bio-pharma Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Bio-pharma Market Size by Type
10.1.1 Middle East, Africa and Latin America Bio-pharma Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Bio-pharma Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Bio-pharma Market Size by Application
10.2.1 Middle East, Africa and Latin America Bio-pharma Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Bio-pharma Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Bio-pharma Sales by Country
10.3.1 Middle East, Africa and Latin America Bio-pharma Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Bio-pharma Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Bio-pharma Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Pfizer Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 F. Hoffmann-La Roche AG
11.2.1 F. Hoffmann-La Roche AG Company Information
11.2.2 F. Hoffmann-La Roche AG Overview
11.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 F. Hoffmann-La Roche AG Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 F. Hoffmann-La Roche AG Recent Developments
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Company Information
11.3.2 Johnson & Johnson Services Overview
11.3.3 Johnson & Johnson Services Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Johnson & Johnson Services Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Services Recent Developments
11.4 Sanofi, Amgen
11.4.1 Sanofi, Amgen Company Information
11.4.2 Sanofi, Amgen Overview
11.4.3 Sanofi, Amgen Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Sanofi, Amgen Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi, Amgen Recent Developments
11.5 AbbVie
11.5.1 AbbVie Company Information
11.5.2 AbbVie Overview
11.5.3 AbbVie Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 AbbVie Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AbbVie Recent Developments
11.6 Merck & Co., Inc
11.6.1 Merck & Co., Inc Company Information
11.6.2 Merck & Co., Inc Overview
11.6.3 Merck & Co., Inc Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Merck & Co., Inc Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck & Co., Inc Recent Developments
11.7 Biogen Idec
11.7.1 Biogen Idec Company Information
11.7.2 Biogen Idec Overview
11.7.3 Biogen Idec Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Biogen Idec Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biogen Idec Recent Developments
11.8 Bayer AG
11.8.1 Bayer AG Company Information
11.8.2 Bayer AG Overview
11.8.3 Bayer AG Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bayer AG Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bayer AG Recent Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Information
11.9.2 Eli Lilly and Company Overview
11.9.3 Eli Lilly and Company Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Eli Lilly and Company Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly and Company Recent Developments
11.10 Novartis AG GlaxoSmithKline Plc
11.10.1 Novartis AG GlaxoSmithKline Plc Company Information
11.10.2 Novartis AG GlaxoSmithKline Plc Overview
11.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis AG GlaxoSmithKline Plc Recent Developments
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Information
11.11.2 Bristol-Myers Squibb Company Overview
11.11.3 Bristol-Myers Squibb Company Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Bristol-Myers Squibb Company Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bristol-Myers Squibb Company Recent Developments
11.12 AstraZeneca PLC
11.12.1 AstraZeneca PLC Company Information
11.12.2 AstraZeneca PLC Overview
11.12.3 AstraZeneca PLC Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 AstraZeneca PLC Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 AstraZeneca PLC Recent Developments
11.13 Abbott Laboratories
11.13.1 Abbott Laboratories Company Information
11.13.2 Abbott Laboratories Overview
11.13.3 Abbott Laboratories Bio-pharma Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Abbott Laboratories Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Abbott Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bio-pharma Industry Chain Analysis
12.2 Bio-pharma Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bio-pharma Production Mode & Process
12.4 Bio-pharma Sales and Marketing
12.4.1 Bio-pharma Sales Channels
12.4.2 Bio-pharma Distributors
12.5 Bio-pharma Customers
13 Market Dynamics
13.1 Bio-pharma Industry Trends
13.2 Bio-pharma Market Drivers
13.3 Bio-pharma Market Challenges
13.4 Bio-pharma Market Restraints
14 Key Findings in The Global Bio-pharma Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Bio-pharma Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Recombinant Proteins
Table 4. Major Manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF)
Table 5. Major Manufacturers of Interferons
Table 6. Major Manufacturers of Recombinant Human Insulin
Table 7. Major Manufacturers of Erythropoietin
Table 8. Major Manufacturers of Vaccines
Table 9. Major Manufacturers of Growth Hormones
Table 10. Major Manufacturers of Purified Proteins
Table 11. Major Manufacturers of Others
Table 12. Global Bio-pharma Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Bio-pharma Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Bio-pharma Revenue by Region (2018-2023) & (US$ Million)
Table 15. Global Bio-pharma Revenue by Region (2024-2029) & (US$ Million)
Table 16. Global Bio-pharma Revenue Market Share by Region (2018-2023)
Table 17. Global Bio-pharma Revenue Market Share by Region (2024-2029)
Table 18. Global Bio-pharma Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 19. Global Bio-pharma Sales by Region (2018-2023) & (K Pcs)
Table 20. Global Bio-pharma Sales by Region (2024-2029) & (K Pcs)
Table 21. Global Bio-pharma Sales Market Share by Region (2018-2023)
Table 22. Global Bio-pharma Sales Market Share by Region (2024-2029)
Table 23. Global Bio-pharma Sales by Manufacturers (2018-2023) & (K Pcs)
Table 24. Global Bio-pharma Sales Share by Manufacturers (2018-2023)
Table 25. Global Bio-pharma Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 26. Global Bio-pharma Revenue Share by Manufacturers (2018-2023)
Table 27. Global Key Players of Bio-pharma, Industry Ranking, 2021 VS 2022 VS 2023
Table 28. Bio-pharma Price by Manufacturers 2018-2023 (USD/Pcs)
Table 29. Global Bio-pharma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Bio-pharma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-pharma as of 2022)
Table 31. Global Key Manufacturers of Bio-pharma, Manufacturing Base Distribution and Headquarters
Table 32. Global Key Manufacturers of Bio-pharma, Product Offered and Application
Table 33. Global Key Manufacturers of Bio-pharma, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Bio-pharma Sales by Type (2018-2023) & (K Pcs)
Table 36. Global Bio-pharma Sales by Type (2024-2029) & (K Pcs)
Table 37. Global Bio-pharma Sales Share by Type (2018-2023)
Table 38. Global Bio-pharma Sales Share by Type (2024-2029)
Table 39. Global Bio-pharma Revenue by Type (2018-2023) & (US$ Million)
Table 40. Global Bio-pharma Revenue by Type (2024-2029) & (US$ Million)
Table 41. Global Bio-pharma Revenue Share by Type (2018-2023)
Table 42. Global Bio-pharma Revenue Share by Type (2024-2029)
Table 43. Bio-pharma Price by Type (2018-2023) & (USD/Pcs)
Table 44. Global Bio-pharma Price Forecast by Type (2024-2029) & (USD/Pcs)
Table 45. Global Bio-pharma Sales by Application (2018-2023) & (K Pcs)
Table 46. Global Bio-pharma Sales by Application (2024-2029) & (K Pcs)
Table 47. Global Bio-pharma Sales Share by Application (2018-2023)
Table 48. Global Bio-pharma Sales Share by Application (2024-2029)
Table 49. Global Bio-pharma Revenue by Application (2018-2023) & (US$ Million)
Table 50. Global Bio-pharma Revenue by Application (2024-2029) & (US$ Million)
Table 51. Global Bio-pharma Revenue Share by Application (2018-2023)
Table 52. Global Bio-pharma Revenue Share by Application (2024-2029)
Table 53. Bio-pharma Price by Application (2018-2023) & (USD/Pcs)
Table 54. Global Bio-pharma Price Forecast by Application (2024-2029) & (USD/Pcs)
Table 55. US & Canada Bio-pharma Sales by Type (2018-2023) & (K Pcs)
Table 56. US & Canada Bio-pharma Sales by Type (2024-2029) & (K Pcs)
Table 57. US & Canada Bio-pharma Revenue by Type (2018-2023) & (US$ Million)
Table 58. US & Canada Bio-pharma Revenue by Type (2024-2029) & (US$ Million)
Table 59. US & Canada Bio-pharma Sales by Application (2018-2023) & (K Pcs)
Table 60. US & Canada Bio-pharma Sales by Application (2024-2029) & (K Pcs)
Table 61. US & Canada Bio-pharma Revenue by Application (2018-2023) & (US$ Million)
Table 62. US & Canada Bio-pharma Revenue by Application (2024-2029) & (US$ Million)
Table 63. US & Canada Bio-pharma Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 64. US & Canada Bio-pharma Revenue by Country (2018-2023) & (US$ Million)
Table 65. US & Canada Bio-pharma Revenue by Country (2024-2029) & (US$ Million)
Table 66. US & Canada Bio-pharma Sales by Country (2018-2023) & (K Pcs)
Table 67. US & Canada Bio-pharma Sales by Country (2024-2029) & (K Pcs)
Table 68. Europe Bio-pharma Sales by Type (2018-2023) & (K Pcs)
Table 69. Europe Bio-pharma Sales by Type (2024-2029) & (K Pcs)
Table 70. Europe Bio-pharma Revenue by Type (2018-2023) & (US$ Million)
Table 71. Europe Bio-pharma Revenue by Type (2024-2029) & (US$ Million)
Table 72. Europe Bio-pharma Sales by Application (2018-2023) & (K Pcs)
Table 73. Europe Bio-pharma Sales by Application (2024-2029) & (K Pcs)
Table 74. Europe Bio-pharma Revenue by Application (2018-2023) & (US$ Million)
Table 75. Europe Bio-pharma Revenue by Application (2024-2029) & (US$ Million)
Table 76. Europe Bio-pharma Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 77. Europe Bio-pharma Revenue by Country (2018-2023) & (US$ Million)
Table 78. Europe Bio-pharma Revenue by Country (2024-2029) & (US$ Million)
Table 79. Europe Bio-pharma Sales by Country (2018-2023) & (K Pcs)
Table 80. Europe Bio-pharma Sales by Country (2024-2029) & (K Pcs)
Table 81. China Bio-pharma Sales by Type (2018-2023) & (K Pcs)
Table 82. China Bio-pharma Sales by Type (2024-2029) & (K Pcs)
Table 83. China Bio-pharma Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Bio-pharma Revenue by Type (2024-2029) & (US$ Million)
Table 85. China Bio-pharma Sales by Application (2018-2023) & (K Pcs)
Table 86. China Bio-pharma Sales by Application (2024-2029) & (K Pcs)
Table 87. China Bio-pharma Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Bio-pharma Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Bio-pharma Sales by Type (2018-2023) & (K Pcs)
Table 90. Asia Bio-pharma Sales by Type (2024-2029) & (K Pcs)
Table 91. Asia Bio-pharma Revenue by Type (2018-2023) & (US$ Million)
Table 92. Asia Bio-pharma Revenue by Type (2024-2029) & (US$ Million)
Table 93. Asia Bio-pharma Sales by Application (2018-2023) & (K Pcs)
Table 94. Asia Bio-pharma Sales by Application (2024-2029) & (K Pcs)
Table 95. Asia Bio-pharma Revenue by Application (2018-2023) & (US$ Million)
Table 96. Asia Bio-pharma Revenue by Application (2024-2029) & (US$ Million)
Table 97. Asia Bio-pharma Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 98. Asia Bio-pharma Revenue by Region (2018-2023) & (US$ Million)
Table 99. Asia Bio-pharma Revenue by Region (2024-2029) & (US$ Million)
Table 100. Asia Bio-pharma Sales by Region (2018-2023) & (K Pcs)
Table 101. Asia Bio-pharma Sales by Region (2024-2029) & (K Pcs)
Table 102. Middle East, Africa and Latin America Bio-pharma Sales by Type (2018-2023) & (K Pcs)
Table 103. Middle East, Africa and Latin America Bio-pharma Sales by Type (2024-2029) & (K Pcs)
Table 104. Middle East, Africa and Latin America Bio-pharma Revenue by Type (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Bio-pharma Revenue by Type (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Bio-pharma Sales by Application (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America Bio-pharma Sales by Application (2024-2029) & (K Pcs)
Table 108. Middle East, Africa and Latin America Bio-pharma Revenue by Application (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Bio-pharma Revenue by Application (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America Bio-pharma Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East, Africa and Latin America Bio-pharma Revenue by Country (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Bio-pharma Revenue by Country (2024-2029) & (US$ Million)
Table 113. Middle East, Africa and Latin America Bio-pharma Sales by Country (2018-2023) & (K Pcs)
Table 114. Middle East, Africa and Latin America Bio-pharma Sales by Country (2024-2029) & (K Pcs)
Table 115. Pfizer Company Information
Table 116. Pfizer Description and Major Businesses
Table 117. Pfizer Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 118. Pfizer Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Pfizer Recent Developments
Table 120. F. Hoffmann-La Roche AG Company Information
Table 121. F. Hoffmann-La Roche AG Description and Major Businesses
Table 122. F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 123. F. Hoffmann-La Roche AG Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. F. Hoffmann-La Roche AG Recent Developments
Table 125. Johnson & Johnson Services Company Information
Table 126. Johnson & Johnson Services Description and Major Businesses
Table 127. Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 128. Johnson & Johnson Services Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Johnson & Johnson Services Recent Developments
Table 130. Sanofi, Amgen Company Information
Table 131. Sanofi, Amgen Description and Major Businesses
Table 132. Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 133. Sanofi, Amgen Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sanofi, Amgen Recent Developments
Table 135. AbbVie Company Information
Table 136. AbbVie Description and Major Businesses
Table 137. AbbVie Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 138. AbbVie Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. AbbVie Recent Developments
Table 140. Merck & Co., Inc Company Information
Table 141. Merck & Co., Inc Description and Major Businesses
Table 142. Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 143. Merck & Co., Inc Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Merck & Co., Inc Recent Developments
Table 145. Biogen Idec Company Information
Table 146. Biogen Idec Description and Major Businesses
Table 147. Biogen Idec Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 148. Biogen Idec Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Biogen Idec Recent Developments
Table 150. Bayer AG Company Information
Table 151. Bayer AG Description and Major Businesses
Table 152. Bayer AG Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 153. Bayer AG Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Bayer AG Recent Developments
Table 155. Eli Lilly and Company Company Information
Table 156. Eli Lilly and Company Description and Major Businesses
Table 157. Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 158. Eli Lilly and Company Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Eli Lilly and Company Recent Developments
Table 160. Novartis AG GlaxoSmithKline Plc Company Information
Table 161. Novartis AG GlaxoSmithKline Plc Description and Major Businesses
Table 162. Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 163. Novartis AG GlaxoSmithKline Plc Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Novartis AG GlaxoSmithKline Plc Recent Developments
Table 165. Bristol-Myers Squibb Company Company Information
Table 166. Bristol-Myers Squibb Company Description and Major Businesses
Table 167. Bristol-Myers Squibb Company Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 168. Bristol-Myers Squibb Company Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Bristol-Myers Squibb Company Recent Developments
Table 170. AstraZeneca PLC Company Information
Table 171. AstraZeneca PLC Description and Major Businesses
Table 172. AstraZeneca PLC Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 173. AstraZeneca PLC Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. AstraZeneca PLC Recent Developments
Table 175. Abbott Laboratories Company Information
Table 176. Abbott Laboratories Description and Major Businesses
Table 177. Abbott Laboratories Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 178. Abbott Laboratories Bio-pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Abbott Laboratories Recent Developments
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Bio-pharma Distributors List
Table 183. Bio-pharma Customers List
Table 184. Bio-pharma Market Trends
Table 185. Bio-pharma Market Drivers
Table 186. Bio-pharma Market Challenges
Table 187. Bio-pharma Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-pharma Product Picture
Figure 2. Global Bio-pharma Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Bio-pharma Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Recombinant Proteins Product Picture
Figure 6. Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Figure 7. Interferons Product Picture
Figure 8. Recombinant Human Insulin Product Picture
Figure 9. Erythropoietin Product Picture
Figure 10. Vaccines Product Picture
Figure 11. Growth Hormones Product Picture
Figure 12. Purified Proteins Product Picture
Figure 13. Others Product Picture
Figure 14. Global Bio-pharma Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 15. Global Bio-pharma Market Share by Application in 2022 & 2029
Figure 16. Metabolic Disorders
Figure 17. Oncology
Figure 18. Neurological Disorders
Figure 19. Cardiovascular Diseases
Figure 20. Inflammatory and Infectious Diseases
Figure 21. Others
Figure 22. Bio-pharma Report Years Considered
Figure 23. Global Bio-pharma Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 24. Global Bio-pharma Revenue 2018-2029 (US$ Million)
Figure 25. Global Bio-pharma Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 26. Global Bio-pharma Revenue Market Share by Region (2018-2029)
Figure 27. Global Bio-pharma Sales 2018-2029 ((K Pcs)
Figure 28. Global Bio-pharma Sales Market Share by Region (2018-2029)
Figure 29. US & Canada Bio-pharma Sales YoY (2018-2029) & (K Pcs)
Figure 30. US & Canada Bio-pharma Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Europe Bio-pharma Sales YoY (2018-2029) & (K Pcs)
Figure 32. Europe Bio-pharma Revenue YoY (2018-2029) & (US$ Million)
Figure 33. China Bio-pharma Sales YoY (2018-2029) & (K Pcs)
Figure 34. China Bio-pharma Revenue YoY (2018-2029) & (US$ Million)
Figure 35. Asia (excluding China) Bio-pharma Sales YoY (2018-2029) & (K Pcs)
Figure 36. Asia (excluding China) Bio-pharma Revenue YoY (2018-2029) & (US$ Million)
Figure 37. Middle East, Africa and Latin America Bio-pharma Sales YoY (2018-2029) & (K Pcs)
Figure 38. Middle East, Africa and Latin America Bio-pharma Revenue YoY (2018-2029) & (US$ Million)
Figure 39. The Bio-pharma Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 40. The Top 5 and 10 Largest Manufacturers of Bio-pharma in the World: Market Share by Bio-pharma Revenue in 2022
Figure 41. Global Bio-pharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 42. Global Bio-pharma Sales Market Share by Type (2018-2029)
Figure 43. Global Bio-pharma Revenue Market Share by Type (2018-2029)
Figure 44. Global Bio-pharma Sales Market Share by Application (2018-2029)
Figure 45. Global Bio-pharma Revenue Market Share by Application (2018-2029)
Figure 46. US & Canada Bio-pharma Sales Market Share by Type (2018-2029)
Figure 47. US & Canada Bio-pharma Revenue Market Share by Type (2018-2029)
Figure 48. US & Canada Bio-pharma Sales Market Share by Application (2018-2029)
Figure 49. US & Canada Bio-pharma Revenue Market Share by Application (2018-2029)
Figure 50. US & Canada Bio-pharma Revenue Share by Country (2018-2029)
Figure 51. US & Canada Bio-pharma Sales Share by Country (2018-2029)
Figu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Biopharmaceuticals market size was valued at US$ 31700 million in 2023. With growing demand in downstream market, the Biopharmaceuticals is forecast to a readjusted size of US$ 55380 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Biopharmaceuticals market. Biopharmaceuticals are expected to show stable growth in the future market. However, product di......

Global Bio-Pharma Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Bio-Pharma market: According to our latest research, the global Bio-Pharma market looks promising in the next 5 years. As of 2022, the global Bio-Pharma market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Bio-Pharma market, with a systematical de......

Global Bio-pharma Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 91

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bio-pharma market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Pfizer - F. Hoffmann-La Roche AG - Johnson & Johnson Services - Sanofi, Amgen - AbbVie - Merck & Co., Inc - Biogen Idec - Bayer AG - E......

Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028

Published: 24-Nov-2023        Price: US 4950 Onwards        Pages: 273

“Rising demand for biopharmaceuticals and growing adoption among CDMOs and CMOs are driving the growth of the continuous bioprocessing market.” The global continuous bioprocessing market is projected to reach USD 599 million by 2028 from USD 218 million in 2023, at a CAGR of 22.4% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing adoption of continuous bioprocessing among CDMOs and CMOs. Continuous b......

Global Biopharmaceuticals Professional Survey Report 2023, Forecast to 2028

Published: 20-Nov-2023        Price: US 3280 Onwards        Pages: 139

A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......

Global Biopharmaceuticals Market Research Report 2023, Forecast to 2028

Published: 20-Nov-2023        Price: US 2680 Onwards        Pages: 160

A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......

2023-2031 Report on Global Biopharmaceuticals Market by Player, Region, Type, Application and Sales Channel

Published: 18-Sep-2023        Price: US 2500 Onwards        Pages: 85

This report studies the Biopharmaceuticals market, covering market size for segment by type (Monoclonal Antibodies, Interferon, etc.), by application (Tumor, Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, Abbvie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Biopharmaceutic......

Global Bio-pharma Market Insights, Forecast to 2029

Published: 10-Aug-2023        Price: US 4900 Onwards        Pages: 108

The global Bio-pharma market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of......

Biopharmaceuticals Markets in China

Published: 24-Jul-2023        Price: US 4000 Onwards        Pages: 233

China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs